SCHEMBL4786321

SCHEMBL4786321

CCC(=O)C(=O)c1ccc(N(C)C)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.60
CES2 O00748 1/20 0.59
CES1 P23141 1/20 0.59
ALDH1A1 P00352 6/20 0.57
MAPT P10636 5/20 0.57
HPGD P15428 3/20 0.57
NPC1 O15118 4/20 0.50
LMNA P02545 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HDAC1 Q13547 4/20 0.46
HDAC3 O15379 2/20 0.46
HDAC2 Q92769 2/20 0.46
HDAC8 Q9BY41 2/20 0.46
HDAC6 Q9UBN7 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
MAPK1 P28482 2/20 0.46
POLB P06746 2/20 0.46
KDM4E B2RXH2 1/20 0.46
ALOX15 P16050 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL194888 0.83 RAB9A (0.83) RAB9ACES2CES1ALDH1A1MAPT
SCHEMBL303244 0.79 ALDH1A1 (0.61) RAB9AALDH1A1MAPTHPGDNPC1
SCHEMBL8695963 0.78 RAB9A (0.63) RAB9AALDH1A1MAPTHPGDNPC1
SCHEMBL9187568 0.77 RAB9A (0.67) RAB9ACES2CES1ALDH1A1MAPT
SCHEMBL4174554 0.77 RAB9A (0.73) RAB9AALDH1A1MAPTHPGDNPC1
SCHEMBL11129136 0.77 RAB9A (0.66) RAB9ACES2CES1ALDH1A1MAPT
Butane SCHEMBL11690769 0.76 MAPT (0.57) RAB9AALDH1A1MAPTHPGDNPC1
SCHEMBL2124043 0.76 RAB9A (0.55) RAB9AALDH1A1MAPTHPGDNPC1
SCHEMBL4140401 0.75 RAB9A (1.00) RAB9ACES2CES1ALDH1A1MAPT
SCHEMBL4785681 0.75 CES2 (0.63) CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008077646-A1 NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-07-03 WO disclosed